[1]
Rana, M.; Ahmedi, S.; Mehandi, R.; Ahmad, S.; Fatima, T.; Raza, K.; Manzoor, N. 2-hydrazinobenzothiazole based derivatives: Synthesis, characterization, antifungal, DNA binding and molecular modelling approaches. Elsevier-. J. Mol. Struct., 2024, 138051.
[http://dx.doi.org/10.1016/j.molstruc.2024.138051]
[http://dx.doi.org/10.1016/j.molstruc.2024.138051]
[2]
Ahmad, S.; Gautam, H.; Singh, V.; Raza, K. Multisampling-based docking reveals Imidazolidinyl urea as a multitargeted inhibitor for Lung Cancer: An optimisation followed multi-simulation and in-vitro study. T & F-. J. Biomol. Struct. Dyn., 2023.
[http://dx.doi.org/10.1080/07391102.2023.2209673]
[http://dx.doi.org/10.1080/07391102.2023.2209673]
[3]
Sahu, A.; Ahmad, S.; Imtiyaz, K.; Kumaran, A.K.; Islam, M.; Raza, K.; Easwaran, M.; Kunnath, A.K.; Rizvi, M.A.; Verma, S. In-silico and in-vitro study reveals ziprasidone as a potential aromatase inhibitor against breast carcinoma. Sci. Rep., 2023.
[http://dx.doi.org/10.1038/s41598-023-43789-1]
[http://dx.doi.org/10.1038/s41598-023-43789-1]
[4]
Ahmad, S.; Raza, K. Identification of 5 nitroindazole as a multitargeted inhibitor for CDK and transferase kinase in lung cancer: A multisampling algorithm based structural study. Springer. Mol. Divers., 2023.
[http://dx.doi.org/10.1007/s11030-023-10648-0]
[http://dx.doi.org/10.1007/s11030-023-10648-0]
[5]
Bhati, R.; Nigam, A.; Ahmad, S.; Raza, K.; Singh, R. , 2023. Structural-functional analysis and Molecular characterisation of arsenate reductase from Enterobacter cloacae RSC3 for arsenic biotransformation. In: Springer-3-Biotech;
[http://dx.doi.org/10.1007/s13205-023-03730-9]
[http://dx.doi.org/10.1007/s13205-023-03730-9]
[6]
Shah, A.A.; Ahmad, S.; Yadav, M.K.; Raza, K.; Kamal, M.A.; Akhtar, S. Structure-based virtual screening, molecular docking, molecular dynamics simulation, and metabolic reactivity studies of quinazoline derivatives for their anti-EGFR activity against tumour angiogenesis. In: Bentham Science- Current Medicinal Chemistry; , 2023.
[http://dx.doi.org/10.2174/0929867330666230309143711]
[http://dx.doi.org/10.2174/0929867330666230309143711]
[7]
Yadav, M.K.; Ahmad, S.; Raza, K.; Kumar, S.; Eswaran, M.; Pasha, K.M.M. Predictive modelling and therapeutic repurposing of natural compounds against the receptor-binding domain of SARS-CoV-2. In: T & F- Journal of Biomolecular Structure and Dynamics; , 2022.
[http://dx.doi.org/10.1080/07391102.2021.2021993]
[http://dx.doi.org/10.1080/07391102.2021.2021993]
[8]
Ahmad, S.; Bano, N.; Qazi, S.; Yadav, MK.; Ahmad, N.; Raza, K. Multitargeted molecular dynamic understanding of Butoxypheser against SARS-CoV-2: An in-silico study. SAGE-Natural Product Communications, 2022.
[http://dx.doi.org/10.1177/1934578X221115499]
[http://dx.doi.org/10.1177/1934578X221115499]
[9]
Ahmad, S.; Pasha, K.M.M.; Raza, K.; Rafeeq, M.M.; Habib, A.H.; Eswaran, M.; Yadav, M.K. Reporting dinaciclib and theodrenaline as a multitargeted inhibitor against SARS-CoV-2: an in-silico study. In: T&F- Journal of Biomolecular Structure and Dynamics; , 2022.
[http://dx.doi.org/10.1080/07391102.2022.2060308]
[http://dx.doi.org/10.1080/07391102.2022.2060308]
[10]
Tarique, M.; Ahmad, S.; Malik, A.; Ahmad, I.; Saeed, M.; Almatroudi, A.; Qadah, T.; Murad, M. A.; Mashraqi, M.; Alam, Q. Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) and other coronaviruses: a genome-wide comparative annotation and analysis. Springer-Molecular and Cellular Biochemistry., 2021.
[http://dx.doi.org/10.1007/s11010-020-04027-8]
[http://dx.doi.org/10.1007/s11010-020-04027-8]